Childhood Malignant Neoplasm — Trials

Childhood Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 263
Recruiting: 158
Ph III recruiting: 9
Growth YoY: −7.4%
Industry share: 8%
Top sponsor: St. Jude Children's Research Hospital
Termination share: 19.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (92)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03126643	Expanded Access to Nivolumab (Opdivo)	approved for marketing	—	—	Bristol-Myers SquibbINDUSTRY	0	Nov 29, 2021	clinicaltrials
NCT03245424	Ivosidenib Expanded Access Program in Relapsed/Refractory AML With an IDH1 Mutation	approved for marketing	—	—	Agios Pharmaceuticals, Inc.INDUSTRY	0	Jul 24, 2018	clinicaltrials